Clinical Trial Update: Treatment of Congenital Stationary Night Blindness With an Alga Containing High Dose of Beta Carotene [NA]

View source ↗

Summary

A clinical trial studied a beta-carotene–rich algae preparation as a potential treatment for congenital stationary night blindness, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Stationary Night Blindness

Drugs mentioned

• Beta-carotene-rich algae extract (beta-carotene)

Snippet

Sponsor: Sheba Medical Center | Conditions: Night Blindness | NA | Status: COMPLETED